Novotech Extends Continued Growth With Oracle

Novotech has selected Oracle’s Siebel Clinical Trial Management System to support the company’s complete spectrum of clinical drug development and research.

Novotech selected Siebel Clinical Trial Management because it met the organisation’s present needs, is a recognised leader and is built on open standards allowing the company to integrate other business applications, such as its financial system.

Siebel Clinical Trial Management will also serve as a centralised repository for all investigators to collect and track relevant information about research, including personal profiles to disease specialities. Information will be readily available to manage clinical trials at different tiers – local, regional and global.

Siebel Clinical Trial Management will offer a consistent view of the clinical trials undertaken by Novotech and provide up to date information on clinical trial statuses across the organisation. Furthermore, Siebel Clinical Trial Management will provide a common platform that will assist Novotech to conduct their activities to achieve operational efficiencies.

More from Biztech

Future Group - Reliance Retail Deal approved by CCI RBI ban on cryptocurrencies takes effect; prohibition could force investors to tap the black market

In addition to managing the end-to-end trial management process, Siebel Clinical Trial Management will assist to provide timely and accurate reports and dashboards to support tactical and strategic decision making.

Novotech expects to see improved process efficiencies, better trial quality and lower trial costs from the implementation. Plans are underway to integrate Siebel Clinical with Novotech’s finance system. This will help streamline the business and support real time and accurate reporting, enabling traceability and auditability, and helping reduce the risk of errors due to manually entered information.

“As we continue to expand, we need a system that can grow with our business operations and support our ability to run successful clinical trials across the globe. Novotech’s investment in this field with industry leading technology systems like Oracle’s Siebel Clinical showcases our efforts to be recognised as a world-class CRO,” said Alek Safarian, CEO Novotech Australia.

“Oracle’s Siebel Clinical Trial Management System is a proven solution for managing successful clinical trials. We are pleased that Novotech recognises the benefits it provides in supporting the company’s ongoing and future clinical drug development and research,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences.